Higuchi Terumi, Yamazaki Toshio, Ohnishi Yoshihiko, Matsumoto Shiro, Yabuki Minako, Kitajima Syoko, Toshida Yoshinori, Maruyama Noriaki, Oikawa Osamu, Okada Kazuyoshi, Fukuda Noboru, Soma Masayoshi, Matsumoto Koichi
Division of Nephrology and Endocrinology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Ther Apher Dial. 2007 Feb;11(1):70-3. doi: 10.1111/j.1744-9987.2007.00457.x.
We report the case of a patient who developed eosinophilia during hemodialysis and became intolerant to dialysis therapy. The patient, a 40-year-old woman, was initiated on hemodialysis for end-stage renal failure caused by chronic glomerulonephritis. After starting on dialysis, her eosinophil count gradually increased. During the ninth session, she developed abdominal pain of an unknown cause after approximately 1 h of dialysis. The symptom, which persisted in the following sessions, was considered to be a dialysis-related complication. We attempted different dialyzers and anticoagulants, but without improvement. The dialysis therapy was discontinued and steroid treatment was given. The hypereosinophilic condition improved rapidly and dialysis therapy was restarted successfully without causing abdominal pain. To investigate the cause of this problem, we measured the leukocyte count and anaphylatoxin C3a level in peripheral blood during dialysis, and compared the results before and after steroid treatment. The results showed that the significant decrease in the leukocyte count observed before steroid treatment was reduced to a mild decrease after steroid treatment. In contrast, C3a did not show a significant difference between the values obtained before and after steroid treatment. These findings suggest that eosinophilia played an important role in the etiology of dialysis intolerance and that C3a was not involved in the decrease in leukocytes under the conditions experienced by the present patient.
我们报告了一例在血液透析期间出现嗜酸性粒细胞增多并对透析治疗不耐受的患者病例。该患者为一名40岁女性,因慢性肾小球肾炎导致终末期肾衰竭而开始接受血液透析。开始透析后,她的嗜酸性粒细胞计数逐渐增加。在第九次透析过程中,透析约1小时后她出现了不明原因的腹痛。该症状在随后的透析过程中持续存在,被认为是一种与透析相关的并发症。我们尝试了不同的透析器和抗凝剂,但均无改善。透析治疗被中断,并给予了类固醇治疗。嗜酸性粒细胞增多的情况迅速改善,透析治疗成功重启且未再引起腹痛。为了调查该问题的原因,我们在透析期间测量了外周血白细胞计数和过敏毒素C3a水平,并比较了类固醇治疗前后的结果。结果显示,类固醇治疗前观察到的白细胞计数显著下降在治疗后降至轻度下降。相比之下,C3a在类固醇治疗前后的值之间没有显著差异。这些发现表明,嗜酸性粒细胞增多在透析不耐受的病因中起重要作用,并且在本患者所经历的情况下,C3a与白细胞减少无关。